Patients with treated hyperthyroidism (stable on antithyroid drugs or post-radioactive iodine therapy) can usually safely use tirzepatide, but baseline TSH and free T4 assessment is mandatory
But things changed quickly: Eli Lilly, the manufacturer of Mounjaro (tirzepatide), increased supply, and the FDA declared the shortage over
an association and a correlation between GLP-1 receptor agonists and psychiatric adverse effects were found
doi: 10.3389/fnut.2022.1013055
It is not just as good as the injection, and it is not far behind
Since it slows down digestion, people may experience nausea, stomach pain, bloating, gas, and other gastrointestinal-related issues after eating large portions or foods that take a long time to digest